Vernell is focused on increasing the momentum in the generics business in its key markets through organic and inorganic growth routes. Growth is well spread across geographies with focus on emerging markets.

The Company continues to evaluate acquisition/partnering opportunities in India, emerging and developed markets to strengthen its business and competitiveness.

Vernell has forayed into high growth potential segments like Biologics, Oncology and injectables.

• Dosage Form Development And Manufacturing
• Contract Manufacturing
• Loan licensing
• One stop shop for all pharmaceutical requirements
• API Development And Production